Kita Kenji 北賢二

… Alternative Names

KITA Kenji 北賢二

Less

Researcher Number	80625252
Other IDs
Affiliation (Current)	2025: 金沢大学, がん進展制御研究所, 特任助手
Affiliation (based on the past Project Information) *help	2018 – 2023: 金沢大学, がん進展制御研究所, 特任助手 2012 – 2014: 金沢大学, がん進展制御研究所, 助手
Review Section/Research Field	Principal Investigator Basic Section 53030:Respiratory medicine-related / Respiratory organ internal medicine
Keywords	Principal Investigator 肺がん / オシメルチニブ / 薬物耐性 / 薬剤耐性 / オルガノイド / 肺癌 / 耐性変異 / 肺腺がん / MET増幅 / 分子標的薬耐性 … More / EGFR-TKI / SHOマウス / 肺腺癌 / EGFR変異肺癌 / EGFR変異肺がん / オシメルチニブ耐性 / Osimertinib / EGFR変異 / PDX / 脳転移 Less

Lung adenocarcinoma organoids to overcome drug resistancePrincipal Investigator
- Principal Investigator
  
  Kita Kenji
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Kanazawa University
Study of osimertinib resistance mechanism against EGFR-positive lung adenocarcinoma using PDX modelPrincipal Investigator
- Principal Investigator
  
  Kita Kenji
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Kanazawa University
Metastasis initiating cell of lung cancer brain metastasesPrincipal Investigator
- Principal Investigator
  
  KITA Kenji
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Kanazawa University

All 2020 2019 2015

All Journal Article

[Journal Article] Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer2020
- Author(s)
  Wang Rong、Yamada Tadaaki、Kita Kenji、Taniguchi Hirokazu、Arai Sachiko、Fukuda Koji、Terashima Minoru、Ishimura Akihiko、Nishiyama Akihiro、Tanimoto Azusa、Takeuchi Shinji、Ohtsubo Koshiro、Wang Wei、Suzuki Takeshi、Yano Seiji et. al.
- Journal Title
  
  Nature Communications
  
  Volume: 11 Issue: 1 Pages: 4607-4607
- DOI
  10.1038/s41467-020-18442-4
- NAID
  120007186801
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07346, KAKENHI-PROJECT-19K07686, KAKENHI-PROJECT-19K22578, KAKENHI-PROJECT-20K22837, KAKENHI-PROJECT-19H03433, KAKENHI-PROJECT-19H03499, KAKENHI-PROJECT-19H03665, KAKENHI-PROJECT-18K06057, KAKENHI-PROJECT-18K08141, KAKENHI-PROJECT-16H06279
[Journal Article] Patient‐derived xenograft models of non‐small cell lung cancer for evaluating targeted drug sensitivity and resistance2019
- Author(s)
  Kenji Kita, Koji Fukuda, Hiro Takahashi, Azusa Tanimoto, Akihiro Nishiyama, Sachiko Arai, Shinji Takeuchi, Kaname Yamashita, Koshiro Ohtsubo, Sakiko Otani, Naohiro Yanagimura, Chiaki Suzuki, Hiroko Ikeda, Masaya Tamura, Isao Matsumoto, Seiji Yano
- Journal Title
  
  Cancer Science
  
  Volume: 110(10) Issue: 10 Pages: 3215-3224
- DOI
  10.1111/cas.14171
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08141, KAKENHI-PROJECT-19K06454, KAKENHI-PROJECT-19H03665, KAKENHI-PUBLICLY-17H05659, KAKENHI-PROJECT-19K22892, KAKENHI-PROJECT-18H03330
[Journal Article] In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line.2015
- Author(s)
  Nanjo S, Yano S, et al.
- Journal Title
  
  Cancer Sci
  
  Volume: 106 Issue: 3 Pages: 244-52
- DOI
  10.1111/cas.12600
- NAID
  120005830611
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PLANNED-22112010, KAKENHI-PLANNED-23112101, KAKENHI-PROJECT-24390209, KAKENHI-PROJECT-24650625, KAKENHI-PROJECT-24659403, KAKENHI-PROJECT-25860640, KAKENHI-PROJECT-26250028, KAKENHI-PROJECT-26293322, KAKENHI-PROJECT-25462190, KAKENHI-PROJECT-25462202

1. 矢野聖二

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. 鈴木健之

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kita Kenji 北賢二

KITA Kenji 北賢二

Research Projects

Research Products

Co-Researchers

Lung adenocarcinoma organoids to overcome drug resistancePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Study of osimertinib resistance mechanism against EGFR-positive lung adenocarcinoma using PDX modelPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Metastasis initiating cell of lung cancer brain metastasesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Patient‐derived xenograft models of non‐small cell lung cancer for evaluating targeted drug sensitivity and resistance2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line.2015

Author(s)

Journal Title

DOI

NAID

Data Source

Kita Kenji 北 賢二

KITA Kenji 北 賢二

Research Projects

Research Products

Co-Researchers

Lung adenocarcinoma organoids to overcome drug resistancePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Study of osimertinib resistance mechanism against EGFR-positive lung adenocarcinoma using PDX modelPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Metastasis initiating cell of lung cancer brain metastasesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Patient‐derived xenograft models of non‐small cell lung cancer for evaluating targeted drug sensitivity and resistance2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line.2015

Author(s)

Journal Title

DOI

NAID

Data Source

Kita Kenji 北賢二

KITA Kenji 北賢二